Engaged Capital Reaches Agreement with Evolent Health for Board Representation and Governance Improvements

Bloomberg and other media sources reported on the agreement reached between Olshan client Engaged Capital and Evolent Health pursuant to which Craig Barbarosh was appointed to the company’s Board of Directors and as a member of its newly-formed Strategy Committee intended to oversee value creation initiatives. As part of the agreement, Evolent Health also agreed to present a proposal to declassify its Board at the upcoming 2021 annual meeting. Steve Wolosky and Ryan Nebel represent Engaged Capital in connection with its investment in Evolent Health.